Tissue engineered advanced therapy medicinal products and drug discovery models - From concepts to effective therapy
2024

Fibrillar Fibronectin in Tissue Engineering

publication Evidence: moderate

Author Information

Author(s): Seungkuk Ahn

Primary Institution: UCD Charles Institute of Dermatology, School of Medicine, University College Dublin

Hypothesis

Can tissue-engineered fibrillar fibronectin matrices improve regenerative medicine and drug discovery models?

Conclusion

Fibrillar fibronectin matrices show potential for enhancing tissue regeneration and improving in vitro model systems.

Supporting Evidence

  • Fibrillar fibronectin serves as a physiological and regenerative building block in tissues.
  • Tissue engineering three-dimensional fibrillar fibronectin matrices is currently challenging.
  • Fibronectin-driven mechanobiology needs to further take account various biological and temporal scales.
  • Future fibronectin research should pursue to improve the engineering platform and mechanobiological understanding of fibrillar fibronectin matrices in three-dimensional context.

Takeaway

Fibrillar fibronectin helps cells grow and heal better, making it important for creating new medical treatments.

Methodology

The study discusses various methods for producing 3D fibrillar fibronectin matrices and their implications for tissue engineering.

Limitations

Current methods for creating fibrillar fibronectin matrices are limited in scalability and reproducibility.

Digital Object Identifier (DOI)

10.1016/j.bbiosy.2024.100104

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication